Intravenous laser blood irradiation in the prevention of infectious and inflammatory complications in puerperas after abdominal delivery


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

Objective. To evaluate the clinical efficiency of intravenous laser blood irradiation (ILBI) in the prevention of infectious and IICs in puerperas after cesarean section. Subject and methods. A study group consisted of 126 puerperas after cesarean section. All the puerperas received antibiotic prophylaxis with amoxiclav 1.2 g intravenously 15 minutes before skin incision. After surgery, the puerperas were divided into 2 groups: 1) 65 puerperas who, beginning from postoperative day 1, underwent daily ILBI using a Solaris device (Russia) with helium-neon laser at a wavelength of 0.63 nm during 15 minutes for 5 days (a study group); 2) 61 puerperas who had antibiotic prophylaxis only (a comparison group). From the first operative days, all the puerperas daily underwent thermometry, assessment of pain intensity according to a visual analogue scale, the breast, and fundal height, ultrasonographic examination of the postpartum uterus, and determination of peripheral blood parameters and C-reactive protein (CRP) levels. The pattern of postoperative complications and the number of hospital bed days were analyzed. Results. The mean age of the puerperas in the study and comparison groups were 31.2±5.4 and 30.5±5.1 years, respectively (р?0.05). All the women had a poor obstetric history and a complicated current pregnancy. The risk factors of postoperative IICs were identified. Prophylactic postoperative ILBI promptly normalized the total count of white blood cells, lowered erythrocyte sedimentation rate, increased lymphocyte and hemoglobin levels, and significantly decreased SRP; postoperative pains were more rapidly relieved and body temperature became normal. Lactation was noted on days 3.8±0.8 and 4.2±0.4 in Groups 1 and 2, respectively. Lactostasis was observed in 5 (8.2%) puerperas in the comparison group and in none in the study group. The babies of the study group puerperas were on breastfeeding in 83.1% of cases and on mixed feeding in 16.9%. In the comparison group, 62.3% of the babies were breastfed, 22.9% and 14.7% were on mixed and formula feeding, respectively. In the postpartum period, Groups 1 and 2 showed physiological puerperium in 95.4 and 86.9% of cases, respectively. Both groups had complications in 4.6 and 13.1%, respectively; moreover, complications, such as wound infection and endometritis, were absent in the study group, which provides an explanation for the larger number of bed days in the comparison group. Group 1 spent fewer (5.8±0.74) postoperative bed days, Group 2 did 6.5±1.3 days. ILBI caused no complications in the puerperas. Conclusion. ILBI was shown to be highly effective and safe in puerperas at risk for postoperative IICs. The absence of adverse reactions caused by ILBI and its safety can recommend the technique to use as part of preventive measures to prevent IICs after cesarean section.

Texto integral

Acesso é fechado

Sobre autores

K. Bykova

Acad. V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of the Russia

Email: k_bykova@oparina4.ru
obstetrician-gynecologist of postdelivery department

T. Fedorova

Acad. V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of the Russia

Email: t_fyodorova@oparina4.ru
Ph, MD, Chief of transfusional department

T. Puchko

Acad. V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of the Russia

Email: t_puchko@oparina4.ru
MD, the leading scientific researcher of delivery department

E. Bakuridze

Acad. V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of the Russia

Email: e_bakuridze@oparina4.ru
PhD, obstetrician-gynecologist of transfusional department

Bibliografia

  1. Орджоникидзе Н.В., Федорова Т.А., Данелян С.Ж. Эндометрит и раневая инфекция у родильниц. Проблемы и пути их решения. Акушерство и гинекология. 2004; 5: 3-5
  2. Касабулатов Н.М. Послеродовой эндометрит: патогенез, особенности клеточного и гуморального иммунитета, диагностика и лечение: Автореф. дис. ... д-ра мед. наук. М.; 2006. 46 с
  3. Сидорова И.С., Макаров И.О., Леваков С.А. Послеродовые гнойновоспалительные заболевания. М.: МИА; 2006. 256 с
  4. Häger R.M., Daltveit A.K., Hofoss D., Nilsen S.T., Kolaas T., Øian P., Henriksen T. Complications of cesarean deliveries: rates and risk factors. Am. J. Obstet. Gynecol. 2004; 190(2): 428-34
  5. Чернуха Е.А. Какова оптимальная частота кесарева сечения в современном акушерстве? Акушерство и гинекология. 2000; 5: 8-12
  6. Серов В.Н. Пути снижения акушерской патологии. Акушерство и гинекология. 2007; 5: 8-12
  7. Краснопольский В.И., Буянова С.Н., Щукина Н.А. Гнойно-септические осложнения в акушерстве и гинекологии: патогенез, диагностика и лечебная тактика. Российский вестник акушера-гинеколога. 2007; 5: 76-81
  8. Пешев Л.П., Евстигнеев А.Р. Квантовая терапия в акушерско-гинекологической клинике. Саранск, Калуга; 2002. 156 с
  9. Гладких С.П., Алексеев Ю.В., Полонский А.К. Молекулярнобиологические основы лазерной и фотодинамической терапии. В кн.: Новые аспекты лазерной медицины и техники на пороге XXI века: Сборник научных трудов № 5. М., Калуга; 2000: 21-8
  10. Pratesi R., Saechi C., eds. Lasers in photomedicine and photobiology. Springer series in optical science. vol.22. Berlin, Heidelberg, New York: Springer-Verlag; 1980: 23-4
  11. Breivik H., Borchgrevink P.C., Allen S.M., Rosseland L.A., Romundstad L., Hals E.K. et al. Assessment of pain. Br. J. Anaesth. 2008; 101(1): 17-24
  12. Мурзабекова Г.С., Валиев Р.К. Факторы риска развития инфекционного воспаления послеродовых осложнений. В кн.: Материалы III Российского форума «Мать и дитя». М.; 2001; ч.1: 124
  13. Su G.D., Gong S.P., Yu Y.H. Intraoperative and postoperative risk factors for surgical site infection following cesarean section. Di Yi Jun Yi Da Xue Bao. 2005; 25(8): 1005-6
  14. Гейниц А.В., Москвин С.В., Ачилов А.А. Внутривенное лазерное облучение крови. М.; 2012. 336 с
  15. Картусова Л.Н. Влияние излучения гелий-неонового лазера на физико-химические свойства крови: Автореф. дис. ... канд. биол. наук. М.; 1996. 26 с
  16. Байбеков И.М., Мавлян-Ходжаев Р.Ш., Эрстекис А.Г., Москвин С.В. Эритроциты в норме, патологии и при лазерных воздействиях. Тверь: Триада-X; 2008. 256 с
  17. Козель А.И., Попов Г.К. Механизм действия лазерного облучения на тканевом и клеточном уровнях. Вестник Российской Академии медицинских наук. 2000; 2: 41-3
  18. Walker J. Relief from chronic by low power laser irradiation. Neurosci. Lett. 1993; 43(2-3): 339-44
  19. Музафалов Ф.Ф. Лазерная терапия хронической боли у онкологических больных. Вопросы онкологии. 2002; 48(1): 91-4
  20. Karu T.I. Photobiology of low-power laser therapy. London: Harward Acad. Publ.; 1992. 187 p
  21. Passarella S., Quagliariello E., Catalano I.M. Laser in biochemistry and medicine. Ital. J. Biochem. 1980; 29: 463-4

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Bionika Media, 2014

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies